A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

January 11, 2023

Primary Completion Date

December 20, 2025

Study Completion Date

March 8, 2031

Conditions
Crohn DiseaseColitis, Ulcerative
Interventions
DRUG

TEV-48574 Dose Regimen A

Subcutaneous (sc) administration using a commercial sc infusion system

DRUG

TEV-48574 Dose Regiment B

Subcutaneous (sc) administration using a commercial sc infusion system

Trial Locations (93)

1085

Teva Investigational Site 51334, Budapest

1090

Teva Investigational Site 33056, Vienna

1478

Teva Investigational Site 41015, Lorenskog

1618

Teva Investigational Site 59197, Sofia

1784

Teva Investigational Site 59196, Sofia

5100

Teva Investigational Site 59243, Gorna Oryahovitsa

15702

Teva Investigational Site 31318, Santiago de Compostela

20089

Teva Investigational Site 30284, Rozzano

20132

Teva Investigational Site 30285, Milan

20157

Teva Investigational Site 30286, Milan

21005

Teva Investigational Site 31293, Huelva

21018

Teva Investigational Site 58330, Vinnytsia

Teva Investigational Site 58331, Vinnytsia

24105

Teva Investigational Site 32793, Kiel

32803

Teva Investigational Site 15375, Orlando

33781

Teva Investigational Site 15359, Pinellas Park

34741

Teva Investigational Site 15357, Kissimmee

40218

Teva Investigational Site 15575, Louisville

45440

Teva Investigational Site 15750, Beavercreek

46026

Teva Investigational Site 31292, Valencia

47150

Teva Investigational Site 15574, New Albany

51688

Teva Investigational Site 32874, Wipperfürth

58002

Teva Investigational Site 58327, Chernivtsi

60031

Teva Investigational Site 15567, Gurnee

63110

Teva Investigational Site 15373, St Louis

64068

Teva Investigational Site 15358, Liberty

66160

Teva Investigational Site 15367, Kansas City

72076

Teva Investigational Site 32795, Tübingen

75701

Teva Investigational Site 15361, Tyler

76008

Teva Investigational Site 58324, Ivano-Frankivsk

76092

Teva Investigational Site 15565, Southlake

77494

Teva Investigational Site 15366, Katy

78229

Teva Investigational Site 15374, San Antonio

78550

Teva Investigational Site 15559, Harlingen

79000

Teva Investigational Site 58329, Lviv

79010

Teva Investigational Site 58325, Lviv

Teva Investigational Site 58332, Lviv

84124

Teva Investigational Site 15364, Salt Lake City

88000

Teva Investigational Site 58322, Uzhhorod

89081

Teva Investigational Site 32794, Ulm

92103

Teva Investigational Site 15556, San Diego

1834111

Teva Investigational Site 80179, Afula

8410101

Teva Investigational Site 80191, Beersheba

89128.

Teva Investigational Site 15369, Las Vegas

615 00

Teva Investigational Site 54221, Brno

339 01

Teva Investigational Site 54222, Klatovy

274 01

Teva Investigational Site 54220, Slaný

0119

Teva Investigational Site 81052, Tbilisi

0180

Teva Investigational Site 81053, Tbilisi

H-1033

Teva Investigational Site 51335, Budapest

H-2600

Teva Investigational Site 51338, Vác

277-0871

Teva Investigational Site 84110, Kashiwa

285-8741

Teva Investigational Site 84114, Sakura

108-8642

Teva Investigational Site 84117, Tokyo

169-0073

Teva Investigational Site 84116, Tokyo

930-8550

Teva Investigational Site 84111, Toyama

85-794

Teva Investigational Site 53565, Bydgoszcz

42-202

Teva Investigational Site 53542, Częstochowa

82-300

Teva Investigational Site 53543, Elblag

80-382

Teva Investigational Site 53544, Gdansk

40-040

Teva Investigational Site 53546, Katowice

30-363

Teva Investigational Site 53560, Krakow

31-156

Teva Investigational Site 53548, Krakow

31-506

Teva Investigational Site 53512, Krakow

57-300

Teva Investigational Site 53547, Kłodzko

90-752

Teva Investigational Site 53515, Lodz

34-400

Teva Investigational Site 53518, Nowy Targ

60-529

Teva Investigational Site 53516, Poznan

60-702

Teva Investigational Site 53566, Poznan

81-756

Teva Investigational Site 53550, Sopot

28-200

Teva Investigational Site 53551, Staszów

71-434

Teva Investigational Site 53508, Szczecin

71-685

Teva Investigational Site 53519, Szczecin

87-100

Teva Investigational Site 53553, Torun

34-100

Teva Investigational Site 53554, Wadowice

00-189

Teva Investigational Site 53557, Warsaw

02-672

Teva Investigational Site 53570, Warsaw

02-786

Teva Investigational Site 53556, Warsaw

04-501

Teva Investigational Site 53555, Warsaw

52-416

Teva Investigational Site 53510, Wroclaw

53-149

Teva Investigational Site 53567, Wroclaw

53-611

Teva Investigational Site 53562, Wroclaw

53-673

Teva Investigational Site 53520, Wroclaw

54-144

Teva Investigational Site 53549, Wroclaw

Teva Investigational Site 53563, Wroclaw

22-400

Teva Investigational Site 53509, Zamość

21-010

Teva Investigational Site 53511, Łęczna

085 01

Teva Investigational Site 62074, Bardejov

811 09

Teva Investigational Site 62073, Bratislava

040 13

Teva Investigational Site 62071, Košice

080 01

Teva Investigational Site 62076, Prešov

Teva Investigational Site 62097, Prešov

SE1 9RT

Teva Investigational Site 34305, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Teva Branded Pharmaceutical Products R&D LLC

INDUSTRY